Concepedia

α-Galactosidase delivery using 30Kc19-human serum albumin nanoparticles for effective treatment of Fabry disease

Hong Jai Lee, Hee Ho Park, Youngsoo Sohn, Jina Ryu, Ju Hyun Park, Won Jong Rhee, Tai Hyun Park

Applied Microbiology and Biotechnology · 2016 · 31 citations · 26 references

DOI

Concepts

References

26

Desolvation process and surface characterisation of protein nanoparticles

Carolin Weber, Conrad Coester, J. Kreuter et al. · International Journal of Pharmaceutics · 2000 · 600 citations

, , +16

Nano and microparticles as controlled drug delivery devices.

M N Ravi Kumar · PubMed · 2000 · 541 citations

, , +17

Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurones

Anja Zensi, David J. Begley, Charles Pontikis et al. · Journal of Controlled Release · 2009 · 428 citations

, , +14

Enzyme therapy for Fabry disease: Neutralizing antibodies toward agalsidase alpha and beta

Gabor E. Linthorst, Carla E. M. Hollak, Wilma E. Donker‐Koopman et al. · Kidney International · 2004 · 281 citations

, , +9

A biochemical and pharmacological comparison of enzyme replacement therapies for the glycolipid storage disorder Fabry disease

K. Lee · Glycobiology · 2003 · 257 citations · Full text

, , +17